Thrombolytic Therapy for Acute Myocardial Infarction
Trials of thrombolytic therapy have taught us that 1) lysis of hemostatic plugs, not fibrinogenolysis, is the major cause of bleeding complications; 2) as currently reported, patency rates 90 minutes after the onset of therapy are both meaningless and misleading as surrogate end-points for either my...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Tex Heart Inst J |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Texas Heart Institute
1991
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC324975/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15227491/ |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|